Dr. Sara Rubenstein, MD
Child Neurology (Neurology with Special Qualifications in Child Neurology Physician)
At a glance
- In the NPI registry since
- 2016
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology with Special Qualifications in Child Neurology Physician primary
NJ license 25MA11076800
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 4 companies reported 15 payments worth $7,127 in total to this clinician.
| Sarepta Therapeutics, Inc. | $6,870 |
|---|---|
| Alexion Pharmaceuticals, Inc. | $140 |
| Novartis Pharmaceuticals Corporation | $101 |
| Neurelis, Inc. | $16.77 |
| Consulting Fee | $5,270 |
|---|---|
| Travel and Lodging | $1,325 |
| Food and Beverage | $532 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sarepta Therapeutics, Inc. Aug 6, 2025 | Consulting Fee Elevidys · Genetic Disease | $5,270 |
| Sarepta Therapeutics, Inc. Jul 18, 2025 | Travel and Lodging Elevidys · Genetic Disease · travel to Washington, DC · in-kind | $670 |
| Sarepta Therapeutics, Inc. Jul 18, 2025 | Travel and Lodging Elevidys · Genetic Disease · travel to Washington, DC · in-kind | $279 |
| Sarepta Therapeutics, Inc. Jul 18, 2025 | Travel and Lodging Elevidys · Genetic Disease · travel to Washington, DC · in-kind | $172 |
| Sarepta Therapeutics, Inc. Jul 19, 2025 | Travel and Lodging Elevidys · Genetic Disease · travel to Washington, DC · in-kind | $172 |
| Sarepta Therapeutics, Inc. Aug 6, 2025 | Travel and Lodging Elevidys · Genetic Disease · travel to Washington, DC · in-kind | $31.94 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.